HemoSense to Hold Fiscal 2007 Third Quarter Financial Results Conference Call on August 7

  
    
  
  
    
      HemoSense, Inc. (AMEX:HEM) today announced that it will release 
      financial results for the three and nine months ended June 30, 2007 
      after market close on Tuesday, August 7, 2007. HemoSense management will 
      host an investment community conference call beginning at 4:30 p.m. 
      Eastern time (1:30 p.m. Pacific time) to discuss those results and 
      answer questions.
    
    
      Individuals interested in participating in the conference call may do so 
      by dialing [phone] for domestic callers, or [phone] for 
      international callers. Those interested in listening to the conference 
      call live via the Internet may do so by visiting the Investors section 
      of the company’s Web site at www.hemosense.com.
    
    
      A telephone replay will be available for 48 hours following the 
      conclusion of the call by dialing [phone] for domestic callers, 
      or [phone] for international callers, and entering reservation 
      code 11125928. A webcast replay will be available for 30 days by 
      visiting the Investors section on the HemoSense Web site.
    
    
      About HemoSense
    
    
      HemoSense is a point-of-care diagnostic healthcare company that 
      initially has developed, manufactures and commercializes easy-to-use, 
      handheld blood coagulation systems for monitoring patients taking 
      warfarin. The HemoSense INRatio® system, used 
      by healthcare professionals and patients themselves, consists of a small 
      monitor and disposable test strips. It provides accurate and convenient 
      measurement of blood clotting time, or PT/INR values. Routine 
      measurements of PT/INR are necessary for the safe and effective 
      management of the patient’s warfarin dosing. 
      INRatio is sold in the United States and internationally. For more 
      information, visit www.hemosense.com.
    
    
      HemoSense® and INRatio® 
      are registered trademarks of HemoSense, Inc.